Item 2. Unregistered Sales of Equity Securities
ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS
The following sets forth information regarding all unregistered securities sold by us in transactions that were exempt from the requirements of the Securities Act during the three months ended March 31, 2025. Except where noted, all of the securities discussed in this Item 2 were all issued in reliance on the exemption under Section 4(a)(2) of the Securities Act.
On February 26, 2025, we issued Tysadco Partners, LLC 139,535 restricted shares for payment of $180,000 in outstanding invoices.
On February 11, 2025, we issued 15,982 restricted
shares related to the issuance of a 2024 convertible note to a non-affiliated individual lender.
On February 11, 2025, we issued 21,552 restricted
shares related to the issuance of a 2024 convertible note to Ballengee Holdings, LLC, an entity controlled by James Ballengee, the Company’s
Chairman, President, and Chief Executive Officer.
On February 11, 2025, we issued 50,000 restricted shares for a reduction
in liabilities related to our consulting agreement with 395 Group, LLC.
We
issued the Sellers in the acquisition of the Endeavor Entities transaction an additional 24,291 shares of our common stock on February 26,
2025, and 107,789 shares of our Series A Preferred Stock on April 11, 2025 as part of the consideration for the transaction, all
of which are considered to have been issued as of December 31, 2024 for accounting purposes.
ITEM 3. DEFAULTS UPON SENIOR SECURITIES
None.
ITEM 4. MINE SAFETY DISCLOSURES
Not Applicable.
31
Text extracted from the filing as submitted to EDGAR. Formatting, tables and exhibits are simplified for reading; the original document is authoritative for anything you rely on.